 Minnie Mc Millan, PhD
 Overview Dr. Minnie McMillan is a Founder of Anergix and member of the Anergix Advisory Board. She is a molecular immunogeneticist and a Professor of Microbiology and Neurology at USC. She obtained B.A., B.Sc. and D.Phil. degrees in Chemistry from Oxford University, England, where she was an Exhibitioner at Somerville College. After emigrating to the United States, she became a Gosney Fellow in Biology in the laboratory of Lee Hood at the California Institute of Technology. She then moved to USC, now the Keck School of Medicine, where she is presently a Professor. Her research focuses on the major histocompatibility complex and its role in autoimmunity, particularly, multiple sclerosis. She has been awarded numerous grants from NIAID and NIGMS and has chaired as well as served on many NIH and NCI review panels.
ORNG Applications Bibliographic
-
Vatakis D, McMillan M. The signal peptide sequence impacts the immune response elicited by a DNA epitope vaccine. Clin Vaccine Immunol. 2011 Oct; 18(10):1776-80. PMID: 21832097; PMCID: PMC3187025.
-
Vatakis DN, Koh YT, McMillan M. CD4+ T cell epitope affinity to MHC II influences the magnitude of CTL responses elicited by DNA epitope vaccines. Vaccine. 2005 Apr 08; 23(20):2639-46. PMID: 15780447.
-
Weiner LP, Louie KA, Atalla LR, Kochounian HH, Du J, Wei W, Hinton DR, Gordon EM, Anderson WF, McMillan M. Gene therapy in a murine model for clinical application to multiple sclerosis. Ann Neurol. 2004 Mar; 55(3):390-9. PMID: 14991817.
-
Louie KA, Dadgari JM, DeBoer BM, Weisbuch H, Snow PM, Cheevers WP, Douvas A, McMillan M. Caprine arthritis-encephalitis virus-infected goats can generate human immunodeficiency virus-gp120 cross-reactive antibodies(1). Virology. 2003 Oct 10; 315(1):217-23. PMID: 14592773.
|
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
|